Market Cap (In JPY)
3.76 Billion
Revenue (In JPY)
61.11 Million
Net Income (In JPY)
-589.21 Million
Avg. Volume
150.42 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 430.0-883.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- JP3311800001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Shizuka Akieda
- Employee Count
- -
- Website
- https://www.cyfusebio.com
- Ipo Date
- 2022-12-01
- Details
- Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.
More Stocks
-
2105
-
NXST
-
5371
-
PTC
-
8059
-
0KCSOPKO Health, Inc.
0KCS
-
INDAGIndag Rubber Limited
INDAG
-
000920Vontron Technology Co., Ltd.
000920